Literature DB >> 28597969

The Role of Epigenetic Regulation and Pluripotency-Related MicroRNAs in Differentiation of Pancreatic Stem Cells to Beta Cells.

Ediz Coskun1, Merve Ercin1, Selda Gezginci-Oktayoglu1.   

Abstract

In this study, we aimed to research the effects of class-I HDACs and glucose on differentiation of pancreatic islet derived mesenchymal stem cells (PI-MSCs) to beta cells. Beta cell differentiation determined by flow cytometric analysis and gene expression levels of PDX1, PAX4, PAX6, NKX6.1, NGN3, INS2, and GLUT2. As a result the valproic acid, is an inhibitor of class-I HDACs, caused the highest beta cell differentiation in PI-MSCs. However, the cells in this group were at early stages of differentiation. Glucose co-administration to this group carried the differentiation to higher levels, but these newly formed beta cells were not functional. Moreover, reduction in the levels of pluripotency factors that Oct3/4, c-Myc, and Nanog were parallel to beta cell differentiation. Also, the levels of HDAC1 and acetylated H3/H4 were increased and methylated H3 was decreased by VPA treatment. In addition, we have detected over expression in genes of miR-18a-5p, miR-19b-5p, miR-30d-3p, miR-124, miR-146a-5p, miR-184, miR-335, and miR-433-5p in parallel to beta cell differentiation. As the conclusion, this study is important for understanding the epigenetic mechanism that controls the beta cell differentation and it suggests new molecules that can be used for diagnosis, and treatment of diabetes. J. Cell. Biochem. 119: 455-467, 2018.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  BETA CELL; DIFFERENTIATION; HISTONE DEACETYLASES; PANCREATIC ISLET DERIVED MESENCHYMAL STEM CELLS; PLURIPOTENCY; microRNAs

Mesh:

Substances:

Year:  2017        PMID: 28597969     DOI: 10.1002/jcb.26203

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Metformin induces mitochondrial remodeling and differentiation of pancreatic progenitor cells into beta-cells by a potential mechanism including suppression of the T1R3, PLCβ2, cytoplasmic Ca+2, and AKT.

Authors:  Ertan Celik; Merve Ercin; Sehnaz Bolkent; Selda Gezginci-Oktayoglu
Journal:  J Physiol Biochem       Date:  2022-07-30       Impact factor: 5.080

2.  Next‑generation sequencing of miRNAs and lncRNAs from rat femur and tibia under mechanical stress.

Authors:  Yiyan Qiu; Guozheng Zhu; Canjun Zeng; Song Yuan; Yuepeng Qian; Zelin Ye; Shanwen Zhao; Runguang Li
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

3.  Reduction of Inflammation and Enhancement of Motility after Pancreatic Islet Derived Stem Cell Transplantation Following Spinal Cord Injury.

Authors:  Erdal Karaoz; Filiz Tepekoy; Irem Yilmaz; Cansu Subasi; Serdar Kabatas
Journal:  J Korean Neurosurg Soc       Date:  2019-02-27

4.  Upregulation of spinal ASIC1 by miR-485 mediates enterodynia in adult offspring rats with prenatal maternal stress.

Authors:  Xue Xu; Yong-Chang Li; Yan-Yan Wu; Yu-Cheng Xu; Rui-Xia Weng; Cai-Lin Wang; Ping-An Zhang; Ying Zhang; Guang-Yin Xu
Journal:  CNS Neurosci Ther       Date:  2020-12-13       Impact factor: 5.243

5.  Expression of the microRNA-30 family in pulmonary arterial hypertension and the role of microRNA-30d-5p in the regulation of pulmonary arterial smooth muscle cell toxicity and apoptosis.

Authors:  Fan Hu; Hanmin Liu; Chuan Wang; Hanwen Li; Lina Qiao
Journal:  Exp Ther Med       Date:  2021-12-02       Impact factor: 2.447

6.  microRNA-181c-5p promotes the formation of insulin-producing cells from human induced pluripotent stem cells by targeting smad7 and TGIF2.

Authors:  Ning Li; Doukou Jiang; Qian He; Fei He; Yang Li; Chunyan Deng; Furong Li
Journal:  Cell Death Dis       Date:  2020-06-15       Impact factor: 8.469

Review 7.  Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells.

Authors:  Felipe Arroyave; Diana Montaño; Fernando Lizcano
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.